2019医学类两院院士推荐提名--何晓顺教授

2019-02-16 不详 网络

中山大学附属第一医院副院长、东院院长。二级教授、器官移植科学科带头人、首席专家、博士生导师、中央保健委员会专家、中国名医百强榜、岭南名医。何晓顺教授是我国著名器官移植专家,长期致力于解决器官移植学科的关键科技问题,在无缺血器官移植、器官捐献、多器官移植与联合器官移植等方面做了大量开拓性工作。他带领的器官移植中心现已开展7000余例肝、肾、心、胰腺、小肠等移植手术。有关何晓顺教授报道:卫健委:今年我

中山大学附属第一医院副院长、东院院长。二级教授、器官移植科学科带头人、首席专家、博士生导师、中央保健委员会专家、中国名医百强榜、岭南名医。何晓顺教授是我国著名器官移植专家,长期致力于解决器官移植学科的关键科技问题,在无缺血器官移植、器官捐献、多器官移植与联合器官移植等方面做了大量开拓性工作。他带领的器官移植中心现已开展7000余例肝、肾、心、胰腺、小肠等移植手术。

有关何晓顺教授报道:

卫健委:今年我国器官捐献例数有望突破6000 慢性肾病“广州模式”全国推广

世界首例“无缺血”肾移植在广州成功实施

医药卫生界占2席!央视“十大科技创新人物”出炉

厉害了!全球首例肝脏“热移植”在广州完成

全球首例“不中断血流”肝移植手术 广东医生成功了

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1661037, encodeId=8cb8166103eed, content=<a href='/topic/show?id=f8833421180' target=_blank style='color:#2F92EE;'>#医学类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34211, encryptionId=f8833421180, topicName=医学类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e73025182843, createdName=xiay994461, createdTime=Wed Jun 26 09:55:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362529, encodeId=8322362529f5, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Tue Mar 12 19:09:06 CST 2019, time=2019-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049063, encodeId=a229104906370, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Feb 16 16:55:00 CST 2019, time=2019-02-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1661037, encodeId=8cb8166103eed, content=<a href='/topic/show?id=f8833421180' target=_blank style='color:#2F92EE;'>#医学类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34211, encryptionId=f8833421180, topicName=医学类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e73025182843, createdName=xiay994461, createdTime=Wed Jun 26 09:55:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362529, encodeId=8322362529f5, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Tue Mar 12 19:09:06 CST 2019, time=2019-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049063, encodeId=a229104906370, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Feb 16 16:55:00 CST 2019, time=2019-02-16, status=1, ipAttribution=)]
    2019-03-12 wxl882001

    了解一下

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1661037, encodeId=8cb8166103eed, content=<a href='/topic/show?id=f8833421180' target=_blank style='color:#2F92EE;'>#医学类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34211, encryptionId=f8833421180, topicName=医学类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e73025182843, createdName=xiay994461, createdTime=Wed Jun 26 09:55:00 CST 2019, time=2019-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362529, encodeId=8322362529f5, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Tue Mar 12 19:09:06 CST 2019, time=2019-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049063, encodeId=a229104906370, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sat Feb 16 16:55:00 CST 2019, time=2019-02-16, status=1, ipAttribution=)]
    2019-02-16 junJUN

    院士是学术至高点,也是大家必争之地呀

    0